| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/12/2001 | EP1132400A1 Novel protein, gene encoding the same and method of utilization thereof |
| 09/12/2001 | EP1132398A2 DNA sequence encoding the specific and antigenic outer membrane protein of salmonella typhi |
| 09/12/2001 | EP1132136A2 Microarray, method for producing the same, and method for correcting inter-pin spotting amount error of the same |
| 09/12/2001 | EP1132099A1 Nucleic acid transporters and medicinal compositions for gene therapy |
| 09/12/2001 | EP1132092A1 Coupling factor 6 inhibitor and potentiator and use thereof |
| 09/12/2001 | EP1132091A1 Treatment for diabetes |
| 09/12/2001 | EP1131636A1 Antibodies to peptides that target git receptors and related methods |
| 09/12/2001 | EP1131633A2 Hiv-specific t-cell induction |
| 09/12/2001 | EP1131471A2 A system for cell-based screening |
| 09/12/2001 | EP1131470A1 Cellular arrays and methods of detecting and using genetic disorder markers |
| 09/12/2001 | EP1131469A2 Visualization of rna in living cells |
| 09/12/2001 | EP1131468A2 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids |
| 09/12/2001 | EP1131467A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/12/2001 | EP1131466A1 Method for the quantitative detection of nucleic acids |
| 09/12/2001 | EP1131465A1 Antisense modulation of interleukin-15 expression |
| 09/12/2001 | EP1131463A1 Use of activated trap for screening for specific inhibitor of trap and method for aiding in the identification of a compound for use in the treatment of diseases or degenerative conditions resulting in increased bone resorption |
| 09/12/2001 | EP1131462A1 Analytical system based upon spore germination |
| 09/12/2001 | EP1131458A1 Viral vectors with late transgene expression |
| 09/12/2001 | EP1131457A1 Systemic viral/ligand gene delivery system and gene therapy |
| 09/12/2001 | EP1131456A2 Vectors for gene mutagenesis and gene discovery by gene trapping |
| 09/12/2001 | EP1131455A1 Truncated nucleic acid sequences of the lettuce mosaic virus capsid gene and their use |
| 09/12/2001 | EP1131454A2 Transcriptional activator nucleic acids, polypeptides and methods of use thereof |
| 09/12/2001 | EP1131453A2 PLANT AMINOACYL-tRNA SYNTHETASES |
| 09/12/2001 | EP1131452A2 Nucleic acid molecules from rice and their use for the production of modified starch |
| 09/12/2001 | EP1131451A2 Genes and vectors for conferring herbicide resistance in plants |
| 09/12/2001 | EP1131450A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
| 09/12/2001 | EP1131449A1 Method for identifying inhibitors of ipc synthase |
| 09/12/2001 | EP1131448A2 Producing antimicrobial cationic peptides as fusion proteins |
| 09/12/2001 | EP1131447A1 Thermostable xylanases |
| 09/12/2001 | EP1131446A1 Coffea arabica mannanase |
| 09/12/2001 | EP1131445A1 Human phospholipases |
| 09/12/2001 | EP1131444A1 Polypeptides having lysophospholipase activity and nucleic acids encoding same |
| 09/12/2001 | EP1131443A2 Human hydrolase proteins |
| 09/12/2001 | EP1131442A1 Genetically modified plants with altered starch |
| 09/12/2001 | EP1131441A1 Thermostable luciferases from photuris pennsylvanica and pyrophorus plagiophthalamus and methods of production |
| 09/12/2001 | EP1131440A2 Process for oxidising terpenes |
| 09/12/2001 | EP1131439A2 Maize dna ligase i orthologue and uses thereof |
| 09/12/2001 | EP1131438A1 Gene coding for an acyltranferase of oil seed rape and uses thereof |
| 09/12/2001 | EP1131437A1 Maize rad23 genes and uses thereof |
| 09/12/2001 | EP1131436A1 Urotensins ii of mammals and their uses |
| 09/12/2001 | EP1131435A2 Endoplasmic reticulum stress transcription factors atf6 and creb-rp |
| 09/12/2001 | EP1131434A2 Apoptosis-inducing factor |
| 09/12/2001 | EP1131433A1 Members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 09/12/2001 | EP1131432A2 Cell surface receptor antigen vaccines |
| 09/12/2001 | EP1131431A2 Nucleic acids and polypeptides having altered expression in the t84 gut barrier model |
| 09/12/2001 | EP1131430A2 Mitogenic regulators |
| 09/12/2001 | EP1131429A1 Calcium binding protein |
| 09/12/2001 | EP1131428A2 Immunoglobulin superfamily proteins |
| 09/12/2001 | EP1131427A1 Mammalian chondromodulin-like protein |
| 09/12/2001 | EP1131426A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 09/12/2001 | EP1131425A2 Inflammation-associated genes |
| 09/12/2001 | EP1131424A2 Mutation of the parkin gene, compositions, methods and uses |
| 09/12/2001 | EP1131423A1 Rgs8like polypeptide and polynucleotides, a member of the regulators of g protein signalling family of polypeptides |
| 09/12/2001 | EP1131421A2 Methods for the preparation by in vivo recombination of nucleic acid and polypeptide libraries and uses thereof |
| 09/12/2001 | EP1131420A1 Nucleic acid isolation |
| 09/12/2001 | EP1131419A1 Methods for validating polypeptide targets that correlate to cellular phenotypes |
| 09/12/2001 | EP1131418A1 Alpha-amylase variants |
| 09/12/2001 | EP1131417A2 Engineered cytotoxic ribonuclease |
| 09/12/2001 | EP1131415A2 Low cost manufacture of oligosaccharides |
| 09/12/2001 | EP1131413A1 Immortalized brain endothelial cells |
| 09/12/2001 | EP1131412A2 Plastid transformation of solanaceous plants |
| 09/12/2001 | EP1131411A2 Suppression of xenotransplant rejection |
| 09/12/2001 | EP1131410A1 Bioengineered tissue constructs and methods for producing and using them |
| 09/12/2001 | EP1131409A2 Method of cloning porcine animals |
| 09/12/2001 | EP1131408A2 Cells, culture methods, and their use in autologous transplantation therapy |
| 09/12/2001 | EP1131406A2 Low oxygen culturing of central nervous system progenitor cells |
| 09/12/2001 | EP1131405A2 Rapid recovery of shoots through thin stem slices after preconditioning of micropropagated fruit tree shoots |
| 09/12/2001 | EP1131358A1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 09/12/2001 | EP1131357A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 09/12/2001 | EP1131356A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 09/12/2001 | EP1131355A1 Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid |
| 09/12/2001 | EP1131354A1 Contraceptive antibody vaccines |
| 09/12/2001 | EP1131350A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 09/12/2001 | EP1131349A2 Potassium channel interactors and uses therefor |
| 09/12/2001 | EP1131347A2 Product |
| 09/12/2001 | EP1131346A1 Heliobacter pylori antigen |
| 09/12/2001 | EP1131333A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF |
| 09/12/2001 | EP1131332A1 Antisense modulation of inhibitor-kappa b kinase-beta expression |
| 09/12/2001 | EP1131153A1 A method for reproducing molecular arrays |
| 09/12/2001 | EP1131107A1 Antisense modulation of inhibitor-kappa b kinase-alpha expression |
| 09/12/2001 | EP1131095A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 09/12/2001 | EP1131088A2 NF-$g(k)B ACTIVATION INHIBITORS, AND THEIR PHARMACEUTICAL USES |
| 09/12/2001 | EP1131087A2 Methods of alleviating cancer symptoms |
| 09/12/2001 | EP1131086A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 09/12/2001 | EP1131079A1 Small functional units of antibody heavy chain variable regions |
| 09/12/2001 | EP1131078A1 Compositions and methods for recombinational cloning of nucleic acid molecules |
| 09/12/2001 | EP1130969A1 Murf2 polypeptides and polynucleotides |
| 09/12/2001 | EP1130961A1 Stabilisation of milk from transgenic animals |
| 09/12/2001 | EP1130960A1 Transgenic animals |
| 09/12/2001 | EP1047445A4 Modified enzymes and their use for peptide synthesis |
| 09/12/2001 | EP0960129A4 MELATONIN 1a RECEPTOR GENE REGULATORY REGIONS AND USES THEREOF |
| 09/12/2001 | EP0871769B1 Process for reducing the formation of artefacts during transcription of ribonucleic acids to deoxyribonucleic acids |
| 09/12/2001 | EP0839206B1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 09/12/2001 | EP0839006B1 Process for stabilizing proteins in an acidic environment with a high-ester pectin |
| 09/12/2001 | EP0814900B1 Method of controlling enzymatic reactions |
| 09/12/2001 | EP0804452B1 Recombinant c140 receptor, its agonists and antagonists |
| 09/12/2001 | EP0771879B1 alpha-ketoglutaric dehydrogenase gen |
| 09/12/2001 | EP0766736B1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 09/12/2001 | EP0745126B1 High lysine derivatives of alpha-hordothionin |
| 09/12/2001 | EP0687300B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |